Tawasol Holdings For Financial Investments and LimeVest Partners offered to acquire remaining 74.08% stake in Alexandria New Medical Center (CASE:AMES) from Abu Dhabi Commercial Bank PJSC (ADX:ADCB) & Others for approximately EGP 550 million on February 17, 2021. Under the terms, Tawasol Holdings will acquire 10.57 million shares at the price of EGP 38.09 per share. As on June 21, 2021, the offer includes the purchase of up to 10.575 million shares at EGP 52 per share to top up its stake to 100%. The offer included purchasing up to 11.53 million shares or 74.08% of the shares of Alexandria New Medical Center at a price of EGP 47.67 per share. On September 20, 2022, the purchase price has been amended for the mandatory purchase offer (MTO) by the LimeVest Tawasol consortium to EGP 49 per share. The transaction is subject to the approval of the Egyptian Financial Regulatory Authority. As of August 29, 2022, Egypt's FRA approves publishing offer to acquire Alexandria New Medical Center.

Tawasol Holdings For Financial Investments and LimeVest Partners completed the acquisition of remaining 74.08% stake in Alexandria New Medical Center (CASE:AMES) from Abu Dhabi Commercial Bank PJSC (ADX:ADCB) & Others for approximately EGP 540 million on September 29, 2022. Zaki Hashem & Partners acted as financial advisor and Prime Holding acted as legal advisor to Tawasol Holdings for Financial Investments and LimeVest Partners.